AXON
Price
$549.00
Change
-$9.42 (-1.69%)
Updated
Apr 3, 01:22 PM (EDT)
Capitalization
43.37B
40 days until earnings call
MBIO
Price
$1.29
Change
-$0.15 (-10.42%)
Updated
Apr 3, 11:07 AM (EDT)
Capitalization
3.97M
Ad is loading...

AXON vs MBIO

Header iconAXON vs MBIO Comparison
Open Charts AXON vs MBIOBanner chart's image
Axon Enterprise
Price$549.00
Change-$9.42 (-1.69%)
Volume$131
Capitalization43.37B
Mustang Bio
Price$1.29
Change-$0.15 (-10.42%)
Volume$6.3K
Capitalization3.97M
AXON vs MBIO Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. MBIO commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a StrongBuy and MBIO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (AXON: $558.42 vs. MBIO: $1.44)
Brand notoriety: AXON and MBIO are both not notable
AXON represents the Aerospace & Defense, while MBIO is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 81% vs. MBIO: 146%
Market capitalization -- AXON: $43.37B vs. MBIO: $3.97M
AXON [@Aerospace & Defense] is valued at $43.37B. MBIO’s [@Biotechnology] market capitalization is $3.97M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $213.07B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $17.09B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 1 FA rating(s) are green whileMBIO’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 1 green, 4 red.
  • MBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than MBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 4 TA indicator(s) are bullish while MBIO’s TA Score has 5 bullish TA indicator(s).

  • AXON’s TA Score: 4 bullish, 2 bearish.
  • MBIO’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, MBIO is a better buy in the short-term than AXON.

Price Growth

AXON (@Aerospace & Defense) experienced а -0.11% price change this week, while MBIO (@Biotechnology) price change was +2.13% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -3.83%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was +14.24%.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.29%. For the same industry, the average monthly price growth was -10.33%, and the average quarterly price growth was -14.47%.

Reported Earning Dates

AXON is expected to report earnings on May 13, 2025.

MBIO is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Aerospace & Defense (-3.83% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (-8.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($43.4B) has a higher market cap than MBIO($3.97M). AXON YTD gains are higher at: -6.041 vs. MBIO (-83.729). AXON has higher annual earnings (EBITDA): 437M vs. MBIO (-22.3M). AXON has more cash in the bank: 986M vs. MBIO (27.5M). MBIO has less debt than AXON: MBIO (983K) vs AXON (722M). AXON has higher revenues than MBIO: AXON (2.08B) vs MBIO (0).
AXONMBIOAXON / MBIO
Capitalization43.4B3.97M1,093,750%
EBITDA437M-22.3M-1,959%
Gain YTD-6.041-83.7297%
P/E Ratio116.34N/A-
Revenue2.08B0-
Total Cash986M27.5M3,585%
Total Debt722M983K73,449%
FUNDAMENTALS RATINGS
AXON vs MBIO: Fundamental Ratings
AXON
MBIO
OUTLOOK RATING
1..100
8411
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
12100
SMR RATING
1..100
47100
PRICE GROWTH RATING
1..100
4198
P/E GROWTH RATING
1..100
63100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AXON's Valuation (92) in the Biotechnology industry is in the same range as MBIO (94) in the Pharmaceuticals Major industry. This means that AXON’s stock grew similarly to MBIO’s over the last 12 months.

AXON's Profit vs Risk Rating (12) in the Biotechnology industry is significantly better than the same rating for MBIO (100) in the Pharmaceuticals Major industry. This means that AXON’s stock grew significantly faster than MBIO’s over the last 12 months.

AXON's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for MBIO (100) in the Pharmaceuticals Major industry. This means that AXON’s stock grew somewhat faster than MBIO’s over the last 12 months.

AXON's Price Growth Rating (41) in the Biotechnology industry is somewhat better than the same rating for MBIO (98) in the Pharmaceuticals Major industry. This means that AXON’s stock grew somewhat faster than MBIO’s over the last 12 months.

AXON's P/E Growth Rating (63) in the Biotechnology industry is somewhat better than the same rating for MBIO (100) in the Pharmaceuticals Major industry. This means that AXON’s stock grew somewhat faster than MBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONMBIO
RSI
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LVO0.720.02
+2.23%
LiveOne
MAS71.061.22
+1.75%
Masco Corp
APAM40.220.61
+1.54%
Artisan Partners Asset Management
STKL4.710.01
+0.21%
SunOpta
UXIN4.30-0.02
-0.46%
Uxin Limited